Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial

dc.creatorDooley, Kelly E.
dc.creatorKaplan, Richard
dc.creatorMwelase, Noluthando
dc.creatorGrinsztejn, Beatriz
dc.creatorTicona, Eduardo
dc.creatorLacerda, Marcus
dc.creatorSued, Omar
dc.creatorBelonosova, Elena
dc.creatorAit-Khaled, Mounir
dc.creatorAngelis, Konstantinos
dc.creatorBrown, Dannae
dc.creatorSingh, Rajendra
dc.creatorTalarico, Christine L.
dc.creatorTenorio, Allan R.
dc.creatorKeegan, Michael R.
dc.creatorAboud, Michael
dc.date.accessioned2019-04-11T12:35:59Z
dc.date.accessioned2023-09-05T16:09:45Z
dc.date.available2019-04-11T12:35:59Z
dc.date.available2023-09-05T16:09:45Z
dc.date.created2019-04-11T12:35:59Z
dc.date.issued2019
dc.identifierDOOLEY, Kelly E. et al. Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial. Clinical Infectious Diseases, p. 1-20, Mar. 2019.
dc.identifier1058-4838
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/32451
dc.identifier10.1093/cid/ciz256
dc.identifier1537-6591
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8675098
dc.languageeng
dc.publisherOxford University Press
dc.rightsopen access
dc.titleDolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial
dc.typeArticle


Este ítem pertenece a la siguiente institución